Sign Up to like & get
recommendations!
2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.13563
Abstract: Key Points Question What are the rates of chronic pain (pain “most days” or “every day”) and high-impact chronic pain (chronic pain that limits life or work activities on most days or every day) incidence…
read more here.
Keywords:
among adults;
cases per;
2019 2020;
persistent chronic ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Current Oncology Reports"
DOI: 10.1007/s11912-021-01152-5
Abstract: Purpose of Review Persistent and chronic pain after cancer surgery is a complex clinical problem. The etiology of pain in these cases is often multifactorial and, in addition to the surgery itself, can include or…
read more here.
Keywords:
surgery;
pain cancer;
cancer surgery;
pain ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Platelets"
DOI: 10.1080/09537104.2019.1636018
Abstract: Abstract Less than 40% of patients with newly diagnosed adult immune thrombocytopenia will show spontaneous recovery within 12 months. Therefore, second-line treatments are frequently used to maintain a hemostatic platelet count or at best to…
read more here.
Keywords:
persistent chronic;
line;
primary persistent;
immune thrombocytopenia ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2023.2198089
Abstract: ABSTRACT Introduction In this paper, we systematically review the efficacy and safety of thrombopoietin receptor agonists (TPORAs) for treatment of persistent and chronic immune thrombocytopenia (ITP) in children and adults. Methods We searched PubMed, MEDLINE,…
read more here.
Keywords:
efficacy safety;
persistent chronic;
meta analysis;
Sign Up to like & get
recommendations!
1
Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18126
Abstract: Thrombopoietin receptor agonists are important therapeutic option in children with immune thrombocytopenia (ITP). We evaluated the response, efficacy, safety of a generic form of romiplostim manufactured in India for treating children with persistent/chronic ITP at…
read more here.
Keywords:
immune thrombocytopenia;
romiplostim;
children persistent;
persistent chronic ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "British journal of haematology"
DOI: 10.1111/bjh.18842
Abstract: Eltrombopag (ELT) is effective and safe in adult persistent/chronic immune thrombocytopenia (p/cITP); a proportion could achieve a sustained response off treatment (SRoT); however, data on children are lacking. We attempted to analyse SRoT of ELT…
read more here.
Keywords:
immune thrombocytopenia;
sustained response;
persistent chronic;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Acta haematologica"
DOI: 10.1159/000521689
Abstract: INTRODUCTION The effectiveness and safety of romiplostim were evaluated by immune thrombocytopenia (ITP) phase (newly diagnosed/persistent/chronic) at romiplostim initiation. METHODS Post hoc analysis of a prospective, German, multicentre, observational study in adults with ITP who…
read more here.
Keywords:
diagnosed persistent;
itp;
persistent chronic;
thrombocytopenia itp ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "ERJ Open Research"
DOI: 10.1183/23120541.00471-2022
Abstract: Introduction The aim of this study was to develop and validate prediction models for risk of persistent chronic cough (PCC) in patients with chronic cough (CC). This was a retrospective cohort study. Methods Two retrospective…
read more here.
Keywords:
chronic cough;
event;
persistent chronic;
prediction ... See more keywords